- Home
- XENE vs FA Comparison
XENE vs FA Comparison
Compare XENE & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- FA
- Stock Information
- Founded
- XENE 1996
- FA 2003
- Country
- XENE Canada
- FA United States
- Employees
- XENE N/A
- FA N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- FA Business Services
- Sector
- XENE Health Care
- FA Consumer Discretionary
- Exchange
- XENE Nasdaq
- FA Nasdaq
- Market Cap
- XENE 3.3B
- FA 3.0B
- IPO Year
- XENE 2014
- FA 2021
- Fundamental
- Price
- XENE $38.52
- FA $18.60
- Analyst Decision
- XENE Strong Buy
- FA Buy
- Analyst Count
- XENE 7
- FA 8
- Target Price
- XENE $56.00
- FA $20.80
- AVG Volume (30 Days)
- XENE 424.9K
- FA 625.1K
- Earning Date
- XENE 02-27-2025
- FA 02-27-2025
- Dividend Yield
- XENE N/A
- FA N/A
- EPS Growth
- XENE N/A
- FA N/A
- EPS
- XENE N/A
- FA 0.03
- Revenue
- XENE N/A
- FA $755,643,000.00
- Revenue This Year
- XENE N/A
- FA $17.68
- Revenue Next Year
- XENE $1,600.08
- FA $81.35
- P/E Ratio
- XENE N/A
- FA $654.57
- Revenue Growth
- XENE N/A
- FA N/A
- 52 Week Low
- XENE $35.53
- FA $14.01
- 52 Week High
- XENE $50.99
- FA $20.79
- Technical
- Relative Strength Index (RSI)
- XENE 42.98
- FA 53.11
- Support Level
- XENE $36.90
- FA $16.91
- Resistance Level
- XENE $41.03
- FA $17.63
- Average True Range (ATR)
- XENE 1.41
- FA 0.50
- MACD
- XENE 0.03
- FA 0.03
- Stochastic Oscillator
- XENE 30.39
- FA 74.12
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
About FA First Advantage Corporation
First Advantage Corp is a provider of employment background screening and verification solutions. The company delivers services and insights that help its customers manage risk and hire talent. The Company has two reportable segments, Americas and International. The Americas segment provides technology solutions for screening, verifications, safety, and compliance in the United States, Canada, and Latin America markets. and the International segment provides technology solutions for screening, verifications, safety, and compliance outside of the Americas. The company derives its maximum revenue from America.